This research is studying Definity ultrasound contrast agent, which is already approved by the Food and Drug Administration (FDA) for the ultrasound evaluation of the liver and heart. This research will investigate the ability to use ultrasound imaging with ultrasound contrast agents to evaluate kidney obstruction. Eligible participants that are enrolled will have two visits (one before and one after the planned surgery to relieve the kidney obstruction).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Time to peak (TTP) ultrasound measurements
Timeframe: Immediately after contrast injected (approximately 30 minutes)
Peak intensity (PI) ultrasound measurements
Timeframe: Immediately after contrast injected (approximately 30 minutes)
Mean transit time (MTT) ultrasound measurements
Timeframe: Immediately after contrast injected (approximately 30 minutes)
Area under the curve (AUC) ultrasound measurements
Timeframe: Immediately after contrast injected (approximately 30 minutes)
Ratio of plateau and peak intensity ultrasound Measurements
Timeframe: Immediately after contrast injected (approximately 30 minutes)